Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and Imaging

Development of PET Radioisotope Copper-64-Labeled Theranostic Immunoliposomes for EGFR Overexpressing Cancer-Targeted Therapy and Imaging

Combining standard surgical procedures with personalized chemotherapy and the continuous monitoring of cancer progression is necessary for effective NSCLC treatment. In this study, we developed liposomal nanoparticles as theranostic agents capable of simultaneous therapy for and imaging of target ca...

Full description

Bibliographic Details
Main Authors: Hwa Yeon Jeong, Seong Jae Kang, Min Woo Kim, In-ho Jeong, Moon Jung Choi, Cheulhee Jung, In Ho Song, Tae Sup Lee, Yong Serk Park
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:International Journal of Molecular Sciences
Subjects:
theranostics
positron emission tomography (PET) imaging
immunoliposomes
epidermal growth factor receptor (EGFR)
copper-64
Online Access:https://www.mdpi.com/1422-0067/25/3/1813

Internet

https://www.mdpi.com/1422-0067/25/3/1813

Similar Items